Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Inventory Average (2016 - 2026)

Ani Pharmaceuticals' Inventory Average history spans 13 years, with the latest figure at $144.8 million for Q4 2025.

  • On a quarterly basis, Inventory Average rose 1.66% to $144.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $144.8 million, a 1.66% increase, with the full-year FY2025 number at $139.9 million, up 12.85% from a year prior.
  • Inventory Average hit $144.8 million in Q4 2025 for Ani Pharmaceuticals, up from $142.4 million in the prior quarter.
  • Over the last five years, Inventory Average for ANIP hit a ceiling of $144.8 million in Q4 2025 and a floor of $60.4 million in Q1 2021.
  • Historically, Inventory Average has averaged $108.0 million across 5 years, with a median of $105.4 million in 2022.
  • Biggest five-year swings in Inventory Average: soared 52.92% in 2022 and later grew 1.66% in 2025.
  • Tracing ANIP's Inventory Average over 5 years: stood at $78.2 million in 2021, then skyrocketed by 34.75% to $105.3 million in 2022, then rose by 3.37% to $108.9 million in 2023, then skyrocketed by 30.78% to $142.4 million in 2024, then rose by 1.66% to $144.8 million in 2025.
  • Business Quant data shows Inventory Average for ANIP at $144.8 million in Q4 2025, $142.4 million in Q3 2025, and $137.9 million in Q2 2025.